101 related articles for article (PubMed ID: 22688350)
21. E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma.
Kwon MJ; Nam ES; Cho SJ; Park HR; Shin HS; Park JH; Park CH; Lee WJ
Ann Surg Oncol; 2010 Feb; 17(2):564-71. PubMed ID: 19841979
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
Vaishnav YN; Pant V
DNA Cell Biol; 1999 Dec; 18(12):911-22. PubMed ID: 10619603
[TBL] [Abstract][Full Text] [Related]
23. E2F2 represses cell cycle regulators to maintain quiescence.
Infante A; Laresgoiti U; Fernández-Rueda J; Fullaondo A; Galán J; Díaz-Uriarte R; Malumbres M; Field SJ; Zubiaga AM
Cell Cycle; 2008 Dec; 7(24):3915-27. PubMed ID: 19066456
[TBL] [Abstract][Full Text] [Related]
24. Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.
Dingar D; Konecny F; Zou J; Sun X; von Harsdorf R
J Mol Cell Cardiol; 2012 Dec; 53(6):820-8. PubMed ID: 22985930
[TBL] [Abstract][Full Text] [Related]
25. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.
Zacharatos P; Kotsinas A; Evangelou K; Karakaidos P; Vassiliou LV; Rezaei N; Kyroudi A; Kittas C; Patsouris E; Papavassiliou AG; Gorgoulis VG
J Pathol; 2004 Jul; 203(3):744-53. PubMed ID: 15221933
[TBL] [Abstract][Full Text] [Related]
26. Making omelets without breaking eggs: E2F-mediated induction of cardiomyoycte cell proliferation without stimulation of apoptosis.
Ebelt H; Liu Z; Müller-Werdan U; Werdan K; Braun T
Cell Cycle; 2006 Nov; 5(21):2436-9. PubMed ID: 17102628
[TBL] [Abstract][Full Text] [Related]
27. Accelerated DNA replication in E2F1- and E2F2-deficient macrophages leads to induction of the DNA damage response and p21(CIP1)-dependent senescence.
Iglesias-Ara A; Zenarruzabeitia O; Fernandez-Rueda J; Sánchez-Tilló E; Field SJ; Celada A; Zubiaga AM
Oncogene; 2010 Oct; 29(41):5579-90. PubMed ID: 20676136
[TBL] [Abstract][Full Text] [Related]
28. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
29. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
31. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568
[TBL] [Abstract][Full Text] [Related]
32. Opposing roles of E2Fs in cell proliferation and death.
Crosby ME; Almasan A
Cancer Biol Ther; 2004 Dec; 3(12):1208-11. PubMed ID: 15662116
[TBL] [Abstract][Full Text] [Related]
33. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
34. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.
Hyde RK; Griep AE
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1509-16. PubMed ID: 11980867
[TBL] [Abstract][Full Text] [Related]
35. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
37. E2F4 is required for cardiomyocyte proliferation.
van Amerongen MJ; Diehl F; Novoyatleva T; Patra C; Engel FB
Cardiovasc Res; 2010 Apr; 86(1):92-102. PubMed ID: 19955219
[TBL] [Abstract][Full Text] [Related]
38. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
[TBL] [Abstract][Full Text] [Related]
39. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
40. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
Good L; Dimri GP; Campisi J; Chen KY
J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
